Retinol
ASP-RET-CT001
Phase 2 small_molecule active
Quick answer
Retinol for Bronchopulmonary Dysplasia is a Phase 2 program (small_molecule) at Aspire Biopharma Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aspire Biopharma Holdings
- Indication
- Bronchopulmonary Dysplasia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active